Showing results (2611-2620 of 3,512) with videos related to

Sort By:
Pageof 352
Eclinicalmedicine|September 17, 2026
Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in DenmarkTrine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, et al.
Eclinicalmedicine|October 5, 2026
Regional inequality in infant RSV morbidity and mortality burden in the era of expanded RSV passive immunisation: a global projection modelling studyShaolong Ren, Bingbing Cong, Jing Zou, et al.
Eclinicalmedicine|October 5, 2026
The effect of SGLT2 inhibitors, GLP-1 receptor agonists, or DPP-4 inhibitors on stroke risk in type 2 diabetes: a nationwide longitudinal cohort study in Sweden with contextualisation analysisAnastasios Mavridis, Tamar Abzhandadze, Dongni Buvarp, et al.
Eclinicalmedicine|October 22, 2026
Relative risk reduction is not enough: why cardiorenal trials should routinely report absolute risk reduction and number needed to treatHussein Zaitoon, Muhammad Abdul-Ghani, Ralph A DeFronzo
Eclinicalmedicine|October 24, 2026
Enterococcus faecalis bacteraemia and infective endocarditis: a systematic review and meta-analysisGiovanni Mori, Alessandro Castelli, Andrea Cordin, et al.
Eclinicalmedicine|January 9, 2024
Combined population genomic screening for three high-risk conditions in Australia: a modelling studyPaul Lacaze, Clara Marquina, Jane Tiller, et al.
Eclinicalmedicine|October 31, 2026
Corrigendum to "Neurodegenerative mortality among National Football League Players"Charlotte B Luster, Bobak Abdolmohammadi, Michael J Mastrodicasa, et al.
Eclinicalmedicine|March 15, 2021
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patientsColin Pawlowski, A J Venkatakrishnan, Christian Kirkup, et al.
Eclinicalmedicine|November 29, 2021
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind studyRui Wan, Xiaorong Dong, Qun Chen, et al.
Eclinicalmedicine|November 15, 2021
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialNiklaus D Labhardt, Mikaela Smit, Ianis Petignat, et al.
Pageof 352